AAREY DRUGS & PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
AAREY DRUGS & PHARMACEUTICALS Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹134 Cr | ₹105 Cr | ₹127 Cr | ₹210 Cr | ₹76 Cr | ₹58 Cr | ₹51 Cr | ₹158 Cr |
Expenses | ₹132 Cr | ₹101 Cr | ₹126 Cr | ₹212 Cr | ₹74 Cr | ₹56 Cr | ₹50 Cr | ₹160 Cr |
Operating Income | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹-1 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹-2 Cr |
Other Income | ₹1 Cr | ₹0 Cr | ₹2 Cr | ₹5 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹6 Cr |
Interest | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
Profit After Tax | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
EPS | ₹0.26 | ₹0.57 | ₹0.44 | ₹0.77 | ₹0.40 | ₹0.31 | ₹0.31 | ₹0.14 |
Industry Peers & Returns | 1W | 1M | 1Y |
AAREY DRUGS & PHARMACEUTICALS | 0.8% | 2.5% | 7.7% |
SUN PHARMACEUTICAL INDUSTRIES | 0.2% | -8.3% | 15.9% |
DIVIS LABORATORIES | -1.9% | 8.6% | 55.9% |
CIPLA | -1.3% | -5.5% | -0.1% |
TORRENT PHARMACEUTICALS | -0.5% | -4.2% | 19.3% |
DR REDDYS LABORATORIES | 0.7% | 5.8% | 6.1% |
MANKIND PHARMA | 1.8% | 0.4% | 16.6% |
ZYDUS LIFESCIENCES | 1.9% | 4.8% | -12.7% |
LUPIN | -1.5% | -6.5% | 21.9% |
AAREY DRUGS & PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 27.24 % |
Y-o-Y | 74.94 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹134 Cr | 27.24 | |
Sep2024 | ₹105 Cr | -17.15 | |
Jun2024 | ₹127 Cr | -39.67 | |
Mar2024 | ₹210 Cr | 175.06 | |
Dec2023 | ₹76 Cr | 32.24 | |
Sep2023 | ₹58 Cr | 13.49 | |
Jun2023 | ₹51 Cr | -67.79 | |
Mar2023 | ₹158 Cr | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -40.89 % |
Y-o-Y | -18.50 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹2 Cr | -40.89 | |
Sep2024 | ₹4 Cr | 216.21 | |
Jun2024 | ₹1 Cr | Positive | |
Mar2024 | ₹-1 Cr | Negative | |
Dec2023 | ₹3 Cr | 46.29 | |
Sep2023 | ₹2 Cr | 37.94 | |
Jun2023 | ₹1 Cr | Positive | |
Mar2023 | ₹-2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -53.39 % |
Y-o-Y | -53.26 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 1.65% | -53.39 | |
Sep2024 | 3.54% | 280.65 | |
Jun2024 | 0.93% | Positive | |
Mar2024 | -0.68% | Negative | |
Dec2023 | 3.53% | 10.66 | |
Sep2023 | 3.19% | 21.29 | |
Jun2023 | 2.63% | Positive | |
Mar2023 | -1.38% | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -55.01 % |
Y-o-Y | -29.68 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹1 Cr | -55.01 | |
Sep2024 | ₹2 Cr | 28.92 | |
Jun2024 | ₹1 Cr | -42.45 | |
Mar2024 | ₹2 Cr | 110.68 | |
Dec2023 | ₹1 Cr | 30.23 | |
Sep2023 | ₹1 Cr | 8.14 | |
Jun2023 | ₹1 Cr | 100.28 | |
Mar2023 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -64.47 % |
Y-o-Y | -59.70 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 0.54 % | -64.47 | |
Sep2024 | 1.52 % | 55.10 | |
Jun2024 | 0.98 % | -3.92 | |
Mar2024 | 1.02 % | -23.88 | |
Dec2023 | 1.34 % | -1.47 | |
Sep2023 | 1.36 % | -4.23 | |
Jun2023 | 1.42 % | 517.39 | |
Mar2023 | 0.23 % | - |
AAREY DRUGS & PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -54.39 % |
Y-o-Y | -35.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.26 | -54.39 | |
Sep2024 | ₹0.57 | 29.55 | |
Jun2024 | ₹0.44 | -42.86 | |
Mar2024 | ₹0.77 | 92.50 | |
Dec2023 | ₹0.4 | 29.03 | |
Sep2023 | ₹0.31 | 0.00 | |
Jun2023 | ₹0.31 | 121.43 | |
Mar2023 | ₹0.14 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD